IWMvsPBE
iShares Russell 2000 ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IWM | PBE | |
|---|---|---|
| Expense ratio | 0.19% | 0.58% |
| Assets | $79.3B | $423M |
| Net flow, 1 month | +$2.1B | +$930K |
| Net flow, 1 year | −$1.3B | +$113M |
| Return, YTD | +12.8% | +15.4% |
| Return, 1 year | +13.7% | +31.8% |
| Avg daily volume | 24.6M | 14K |
| Holdings | 1941 | 31 |
| Listed | May 22, 2000 | Jun 23, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS